Chengdu Kanghong Pharmaceutical Hits Day Low Amid Price Pressure at CNY 27.11

Chengdu Kanghong Pharmaceutical Group Co., Ltd. experienced a notable decline today, with the stock dropping by 3.07% on March 3, 2026. The stock reached an intraday low of CNY 27.11, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 5.66%, contrasting with the China Shanghai Composite, which gained 0.41% during the same period. In terms of longer-term performance, Chengdu Kanghong has shown a year-to-date decline of 9.28%, while the broader market has increased by 2.85%. However, the company has demonstrated resilience over the past year, achieving a return of 42.21%, significantly outperforming the China Shanghai Composite's 22.49% return. Key financial metrics indicate a strong operational foundation, with an operating cash flow of CNY 1,486.73 million and a debt-equity ratio of -67.07%. The company maintains a return on equity of 13.70% and a price-to-book value of 2.85, suggesting an attractive valuation in the pharmaceuticals and biotechnology sector.